Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 2/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.45 |
| ▸ | FBP1 | P09467 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28137572 | 0.87 | TSHR (0.61) | ENPP2TSHRALDH1A1MAPTGSK3B | |
| SCHEMBL28886 | 0.87 | APP (0.35) | ENPP2TSHRMEN1ALDH1A1MAPT | |
| SCHEMBL9289 | 0.87 | TSHR (0.61) | ENPP2TSHRALDH1A1MAPTGSK3B | |
| SCHEMBL2817154 | 0.87 | TSHR (0.61) | ENPP2TSHRALDH1A1MAPTGSK3B | |
| SCHEMBL31261443 | 0.85 | ENPP2 (0.48) | ENPP2TSHRMEN1ALDH1A1MAPT | |
| Formaldehyde SCHEMBL27996410 | 0.84 | TSHR (0.52) | ENPP2TSHRMEN1ALDH1A1MAPT | |
| Fluoride SCHEMBL28362409 | 0.84 | TSHR (0.58) | ENPP2TSHRALDH1A1MAPTGSK3B | |
| Hydrochloric Acid SCHEMBL19327577 | 0.84 | TSHR (0.58) | ENPP2TSHRALDH1A1MAPTGSK3B | |
| Hydrochloric Acid SCHEMBL9124177 | 0.84 | CYP3A4 (0.33) | ENPP2TSHRMEN1ALDH1A1MAPT | |
| SCHEMBL27977620 | 0.84 | TSHR (0.58) | ENPP2TSHRALDH1A1MAPTGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109796418-A | Phenylalanine derivative and the preparation method and application thereof containing 4- phenyl -1,2,3- triazole | 山东大学 | 2019-05-24 | — | — | CN | claimed |
| EP-2139884-B1 | PROCESS FOR PREPARING OF 2'-DEOXY-2'2'-DIFLUOROCYTIDINE | DONGWOO SYNTECH CO LTD (KR) | 2013-12-04 | — | — | EP | claimed |
| US-7994310-B2 | Process for preparing 2′-deoxy-2′, 2′-difluorocytidine | DONGWOO SYNTECH CO., LTD. (KR) | 2011-08-09 | — | — | US | claimed |
| US-20100069625-A1 | PROCESS FOR PREPARING OF 2'-DEOXY-2'2'-DIFLUOROCYTIDINE | DONGWOO SYNTECH CO., LTD (KR) | 2010-03-18 | — | — | US | claimed |
| EP-2139884-A1 | PROCESS FOR PREPARING OF 2'-DEOXY-2'2'-DIFLUOROCYTIDINE | Dongwoo Syntech Co., Ltd. (KR) | 2010-01-06 | — | — | EP | claimed |
| WO-2008117955-A1 | PROCESS FOR PREPARING OF 2'-DEOXY-2'2'-DIFLUOROCYTIDINE | DONGWOO SYNTECH CO., LTD. (KR) | 2008-10-02 | — | — | WO | claimed |
| EP-1126833-A4 | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | TREGA BIOSCIENCES INC (US) | 2004-09-08 | — | — | EP | claimed |
| US-20030092634-A1 | Novel compounds and compositions as protease inhibitors | AXYS PHARMACEUTICALS, INC. | 2003-05-15 | — | — | US | claimed |
| US-6506733-B1 | Which process comprises hydrogenating a compound of Formula 9: presence of a catalytic amount of 20% palladium hydroxide on carbon. | AXYS PHARMACEUTICALS, INC. | 2003-01-14 | — | — | US | claimed |
| US-6388081-B1 | 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries | LION BIOSCIENCE AG (DE) | 2002-05-14 | — | — | US | claimed |
| WO-2001000594-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-01-04 | — | — | WO | claimed |
| WO-2000055124-A2 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | claimed |
| WO-2000045635-A1 | THIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2000-08-10 | — | — | WO | claimed |
| WO-2000025768-A1 | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | TREGA BIOSCIENCES, INC. (US) | 2000-05-11 | — | — | WO | claimed |
| EP-0983507-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | Trega Biosciences, Inc. (US) | 2000-03-08 | — | — | EP | claimed |
| EP-0977989-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1998034115-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998034111-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| US-5049551-A | Antitumor | UBE INDUSTRIES, LTD. (JP) | 1991-09-17 | — | — | US | claimed |
| EP-0400610-A1 | 5-Fluorouracil derivatives | UBE INDUSTRIES, LTD. (JP) | 1990-12-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069625-A1 | PROCESS FOR PREPARING OF 2'-DEOXY-2'2'-DIFLUOROCYTIDINE | DPYD, DUT, DHPS | ENPP2 3295/4885TSHR 2364/4885MEN1 3589/4885 |
| US-20030092634-A1 | Novel compounds and compositions as protease inhibitors | SERPINB1, HPN, CTRL | ENPP2 616/4885TSHR 4781/4885MEN1 4105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.